Testing effectiveness (Phase 2)Study completedNCT00850512
What this trial is testing
Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) in Elderly (More Than 60 Years) Patients With Diffuse Large B Cell Lymphoma After 4 Cycles of CHOP21-Rituximab (CHOP21-R) Therapy
Who this might be right for
Diffuse Large B-Cell Lymphoma
University of Bologna 55